Clinical Programs
 Phase 2

Currently in Design (Will be posted on May 2020)

Drug: IDX-1197

Condition: Selected Solid Tumors

 

Contact:  info@idience.com

Location: United States

 Phase 1B / 2A

Drug: IDX-1197

Condition: Solid Tumors

Recruitment Status: Recruiting

Sponsor: Idience Co., Ltd.

Collaborator: IlDong Pharmaceutical Co Ltd

 

Contact:  info@idience.com

Location: Korea, Republic of

 Phase 1A

Drug: IDX-1197

Condition: Advanced Solid Tumors

Recruitment Status: Recruiting

Sponsor: National OncoVenture

Collaborator: IlDong Pharmaceutical Co Ltd

Contact:  info@idience.com

Location: Korea, Republic of

 IDX-1197 Clinical Trials
logo.png

Contact​

info@idience.com

Phone +82-2-526-3622

Fax +82-2-526-3620

2, Baumoe-ro 27-gil, Seocho-gu,

Seoul 06752

Korea

All rights reserved. Idience Co., Ltd